A randomized, prospective, placebo-controlled, double blind trial to evaluate the efficacy of pre-op aprepitant plus ondansetron vs ondansetron plus placebo in patients at moderate-to-high risk post-op nausea (PONV) undergoing ambulatory plastic surgery.

Trial Profile

A randomized, prospective, placebo-controlled, double blind trial to evaluate the efficacy of pre-op aprepitant plus ondansetron vs ondansetron plus placebo in patients at moderate-to-high risk post-op nausea (PONV) undergoing ambulatory plastic surgery.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2014

At a glance

  • Drugs Aprepitant (Primary) ; Ondansetron
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Nov 2011 Planned end date changed from 1 Jun 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.
    • 01 Nov 2010 Status changed from recruiting to completed, according to publication of results.
    • 20 Oct 2010 Results were reported at the 2010 Annual Meeting of the American Society of Anesthesiologists.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top